deferasirox has been researched along with Colitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chunyu, W; Gao, X; Liu, S; Peng, M; Ran, L; Sun, L; Wan, J; Wang, Y; Wu, Y; Yang, K; Yang, Y; Yin, M | 1 |
1 other study(ies) available for deferasirox and Colitis
| Article | Year |
|---|---|
Deferasirox alleviates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and improving intestinal microbiota.
Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Deferasirox; Dextran Sulfate; Disease Models, Animal; Ferroptosis; Gastrointestinal Microbiome; Iron; Mice; Mice, Inbred C57BL; RNA, Ribosomal, 16S; Sodium Chloride; Sodium Chloride, Dietary | 2023 |